The Effect of Treating Patients with Anaemia in Diabetic Nephropathy to different target haemoglobin levels with Epoetin Beta
Latest Information Update: 06 Sep 2021
At a glance
- Drugs Epoetin beta (Primary)
- Indications Anaemia
- Focus Adverse reactions; Therapeutic Use
- Acronyms ESA-2
- 09 Feb 2009 Status is now discontinued, as reported by ISRCTN: Current Controlled Trials.
- 25 Apr 2007 New trial record.